The PIONEER Initiative: Precision Insights On N-of-1 Effectiveness Research. Tissue Ownership by the Individual With the Return of Actionable Information to the Individual Patient and Physician (Precision Oncology)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03896958

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:55.312241+00:00

Published At

2020-12-04T00:00:00+00:00

Record Updated At

2020-12-04

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Cancer, All Types", "Cancer of Liver", "Cancer of Stomach", "Cancer of Head and Neck", "Cancer of Rectum", "Cancer of Kidney", "Cancer of Esophagus", "Cancer of Colon", "Cancer Skin", "Cancer of Cervix", "Cancer, Metastatic", "Cancer of Larynx", "Cancer of Neck", "Cancer of Lung", "Cancer of Brain and Nervous System", "Cancer of Vulva, Disseminated", "Cancer of Pancreas", "Sarcoma", "GIST", "Small-cell Lung Cancer", "Adenocarcinoma Lung", "Cancer of Prostate", "Cancer, Advanced", "Adrenal Cancer", "Testicular Cancer", "Uterine Cancer", "Bronchoalveolar Cell Lung Cancer", "Cancer Unknown Primary", "Glioblastoma Multiforme", "Oligodendroglioma", "Breast Cancer", "Renal Cell Carcinoma", "Hepatocellular Carcinoma", "Cholangiocarcinoma", "Squamous Cell Carcinoma", "Transitional Cell Carcinoma", "Cancer, Other", "Cancer, Anal", "Melanoma", "Cancer, Bile Duct", "Cancer, Bladder", "Cancer Cords Vocal", "Cancers Cell Neuroendocrine", "Cancer Differentiated Poorly", "Cancer, Anaplastic Thyroid"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2020-12-04"

protocolSection.identificationModule.nctId

"NCT03896958"

protocolSection.identificationModule.officialTitle

"The PIONEER Initiative: Precision Insights On N-of-1 Effectiveness Research. Tissue Ownership by the Individual With the Return of Actionable Information to the Individual Patient and Physician (Precision Oncology)"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Cancer, All Types (protocolSection.conditionsModule.conditions)
• Cancer of Liver (protocolSection.conditionsModule.conditions)
• Cancer of Stomach (protocolSection.conditionsModule.conditions)
• Cancer of Head and Neck (protocolSection.conditionsModule.conditions)
• Cancer of Rectum (protocolSection.conditionsModule.conditions)
• Cancer of Kidney (protocolSection.conditionsModule.conditions)
• Cancer of Esophagus (protocolSection.conditionsModule.conditions)
• Cancer of Colon (protocolSection.conditionsModule.conditions)
• Cancer Skin (protocolSection.conditionsModule.conditions)
• Cancer of Cervix (protocolSection.conditionsModule.conditions)
• Cancer, Metastatic (protocolSection.conditionsModule.conditions)
• Cancer of Larynx (protocolSection.conditionsModule.conditions)
• Cancer of Neck (protocolSection.conditionsModule.conditions)
• Cancer of Lung (protocolSection.conditionsModule.conditions)
• Cancer of Brain and Nervous System (protocolSection.conditionsModule.conditions)
• Cancer of Vulva, Disseminated (protocolSection.conditionsModule.conditions)
• Cancer of Pancreas (protocolSection.conditionsModule.conditions)
• Sarcoma (protocolSection.conditionsModule.conditions)
• GIST (protocolSection.conditionsModule.conditions)
• Small-cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Adenocarcinoma Lung (protocolSection.conditionsModule.conditions)
• Cancer of Prostate (protocolSection.conditionsModule.conditions)
• Cancer, Advanced (protocolSection.conditionsModule.conditions)
• Adrenal Cancer (protocolSection.conditionsModule.conditions)
• Testicular Cancer (protocolSection.conditionsModule.conditions)
• Uterine Cancer (protocolSection.conditionsModule.conditions)
• Bronchoalveolar Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Cancer Unknown Primary (protocolSection.conditionsModule.conditions)
• Glioblastoma Multiforme (protocolSection.conditionsModule.conditions)
• Oligodendroglioma (protocolSection.conditionsModule.conditions)
• Breast Cancer (protocolSection.conditionsModule.conditions)
• Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Hepatocellular Carcinoma (protocolSection.conditionsModule.conditions)
• Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
• Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Transitional Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Cancer, Other (protocolSection.conditionsModule.conditions)
• Cancer, Anal (protocolSection.conditionsModule.conditions)
• Melanoma (protocolSection.conditionsModule.conditions)
• Cancer, Bile Duct (protocolSection.conditionsModule.conditions)
• Cancer, Bladder (protocolSection.conditionsModule.conditions)
• Cancer Cords Vocal (protocolSection.conditionsModule.conditions)
• Cancers Cell Neuroendocrine (protocolSection.conditionsModule.conditions)
• Cancer Differentiated Poorly (protocolSection.conditionsModule.conditions)
• Cancer, Anaplastic Thyroid (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.